iBio CFO Robert Lutz resigns effective February 10, 2023

iBio, Inc.

Robert Lutz, CFO and Chief Business Officer, notified iBio of resignation on January 11, 2023.
Resignation effective February 10, 2023; Lutz leaving to pursue another opportunity.
No disagreement with company's strategy, operations, policies, or accounting practices.
No successor named at this time.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Lutz

Chief Financial and Business Officer

IBIO · iBio, Inc.

Effective: 2023-02-10
Filed: January 17, 2023, 6:59 PM ET

On January 11, 2023, Mr. Robert Lutz, the Chief Financial and Business Officer of iBio, Inc. (the “Company”) provided the Company notice of his resignation as an executive officer of the Company, effective February 10, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Lutz resigned as Chief Financial and Business Officer at iBio, Inc..

Action: resigned
Role: Chief Financial and Business Officer

Exact text from the filing

On January 11, 2023, Mr. Robert Lutz, the Chief Financial and Business Officer of iBio, Inc. (the “Company”) provided the Company notice of his resignation as an executive officer of the Company, effective February 10, 2023.

View on SEC.gov

iBio, Inc. filing history →

Source: SEC EDGAR

accession 0001420720-23-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.